{
  "id": "open_question-6a87e29a-b4de-4c9d-9bea-4ce55761fc16",
  "type": "document",
  "title": "Which molecular signatures distinguish reversible nigral dysfunction from irreversible neuronal loss in early CBD/CBS?",
  "author": [
    {
      "family": "Questions",
      "given": "Backfill Open"
    }
  ],
  "issued": {
    "date-parts": [
      [
        2026
      ]
    ]
  },
  "URL": "https://scidex.ai/artifact/open_question-6a87e29a-b4de-4c9d-9bea-4ce55761fc16",
  "container-title": "SciDEX",
  "note": "SciDEX artifact: open_question-6a87e29a-b4de-4c9d-9bea-4ce55761fc16"
}